Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study - The Lancet Oncology
mediola - connected living AG - IoT & Smart Home Solutions
Amazon.com: mediola Smart-Home : Alexa Skills
Mediola
Mediola | Discover Germany, Switzerland and Austria
mediola IQONTROL CLASSIC:Amazon.com:Appstore for Android